EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Type 2 diabetes mellitus exacerbates vaginal group B Streptococcus colonization via impaired mucosal cytokine response

Clare M Robertson, Vicki Mercado-Evans, Addison B Larson, Holly Branthoover, Samantha Ottinger, Marlyd E Mejia, Zainab A Hameed, Lindsey A Gonzalez, Camille Serchejian, Libbie Ogilvie, Jacob J Zulk iD, Kathryn A Patras iD

mSphere · 28.07.2026 · 11 (7)

DOI: 10.1128/msphere.00027-26 ↗

Kurz gefasst

Fachartikel in der Zeitschrift mSphere, erschienen am 28.07.2026. Verfasst von Clare M Robertson und 11 weiteren Autor:innen. Beteiligte Einrichtung: Department of Molecular Virology and Microbiology, Baylor College of Medicine, Houston, Texas, USA. Hauptthemen laut MEDLINE: Vagina, Cytokines, Streptococcus agalactiae, Streptococcal Infections. Die Arbeit nennt 126 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: National Institute of Allergy and Infectious Diseases, Eunice Kennedy Shriver National Institute of Child Health and Human Development, NIDDK NIH HHS.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Type 2 diabetes mellitus (T2D) is a metabolic disorder that confers increased risk of microbial infections, including those caused by the opportunistic pathogen group B Streptococcus (GBS). Asymptomatic GBS vaginal carriage is a notable reservoir for infection, but the impact of T2D on the vaginal mucosa and GBS colonization is not fully understood. We employed a diet-induced mouse model of T2D to investigate the impact of diabetes on glucose availability, vaginal microbiome composition, and vaginal cytokines at baseline and in response to GBS. We observed enhanced susceptibility of diabetic mice to GBS vaginal colonization and reproductive tract dissemination. Despite experiencing hyperglycemia, diabetic mice did not exhibit elevated glucose in the reproductive tract. Regarding the vaginal microbiota, diabetic mice had minimal compositional differences, with decreased Mammaliicoccus being the only significant taxonomic variance. Vaginal cytokine profiling revealed consistently depressed cytokines in diabetic mice, beginning with KC at baseline and expanding to eight pro-inflammatory cytokines post-GBS infection. Diabetic mice exhibited decreased proportions of uterine neutrophils and, following GBS exposure, also displayed an expanded vaginal γδ T cell compartment compared with controls. Pairing cytokine observations with GBS colonization revealed a correlation between delayed vaginal IL-1α induction and persistent vaginal GBS, suggesting that vaginal cytokine deficiency may contribute to diabetic GBS phenotypes. Intravaginal supplementation with rIL-1α resolved GBS burden differences between diabetic mice and controls, confirming that deficient vaginal cytokines contribute to diabetic GBS vaginal persistence. These findings advance our understanding of diabetic vaginal mucosal susceptibility to pathogens and support the potential for immunological intervention. IMPORTANCE People with T2D are more susceptible to microbial infections, but there is limited understanding of the mechanisms that drive this vulnerability. One possibility is that T2D enhances the colonization of opportunistic pathogens, like GBS, in mucosal reservoirs as a precursor to infection. In this study, we used a diabetic mouse model to test whether diabetes alters the vaginal mucosa to promote GBS colonization. We found that increased vaginal GBS colonization in diabetic mice was not linked to tissue glucose availability or changes in the vaginal microbiome but instead was associated with impaired vaginal immune responses. These findings provide a foundation for translational approaches to reduce GBS persistence and dissemination in at-risk individuals.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

VaginaCytokinesStreptococcus agalactiaeStreptococcal InfectionsDiabetes Mellitus, Type 2Mucous MembraneImmunity, MucosalAnimalsFemaleMiceMice, Inbred C57BLMicrobiotaDisease Models, Animal

Stichwörter der Autor:innen

diabetesgroup B Streptococcusvaginal microbiotavaginal mucosal immunity

Substanzen

Cytokines

Autor:innen und Institutionen

  • Department of Molecular Virology and Microbiology, Baylor College of Medicine, Houston, Texas, USA.
  • Alkek Center for Metagenomics and Microbiome Research, Baylor College of Medicine, Houston, Texas, USA.

ORCID-Profile: Jacob J Zulk, Kathryn A Patras

Förderung

  • National Institute of Allergy and Infectious Diseases
  • Eunice Kennedy Shriver National Institute of Child Health and Human Development
  • NIDDK NIH HHS
  • NIAID NIH HHS
  • NICHD NIH HHS
  • Burroughs Wellcome Fund
  • NIGMS NIH HHS
  • NCI NIH HHS

Zitieren

APA

Robertson, C. M., Mercado-Evans, V., Larson, A. B., Branthoover, H., Ottinger, S., Mejia, M. E., Hameed, Z. A., Gonzalez, L. A., Serchejian, C., Ogilvie, L., Zulk, J. J., & Patras, K. A. (2026). Type 2 diabetes mellitus exacerbates vaginal group B Streptococcus colonization via impaired mucosal cytokine response. mSphere, 11(7). https://doi.org/10.1128/msphere.00027-26

Vancouver

Robertson CM, Mercado-Evans V, Larson AB, Branthoover H, Ottinger S, Mejia ME, et al. Type 2 diabetes mellitus exacerbates vaginal group B Streptococcus colonization via impaired mucosal cytokine response. mSphere. 2026;11(7). doi:10.1128/msphere.00027-26

BibTeX
@article{Robertson2026,
  author = {Robertson, Clare M and Mercado-Evans, Vicki and Larson, Addison B and Branthoover, Holly and Ottinger, Samantha and Mejia, Marlyd E and Hameed, Zainab A and Gonzalez, Lindsey A and Serchejian, Camille and Ogilvie, Libbie and Zulk, Jacob J and Patras, Kathryn A},
  title = {Type 2 diabetes mellitus exacerbates vaginal group B Streptococcus colonization via impaired mucosal cytokine response},
  journal = {mSphere},
  year = {2026},
  volume = {11},
  number = {7},
  doi = {10.1128/msphere.00027-26}
}
Kostenlos starten →